Pfizer Inc. stock rises Tuesday, still underperforms market
Shares of Pfizer Inc. PFE inched 0.11% higher to $26.74 Tuesday, on what proved to be an all-around great trading session for ...
Sickle cell disease drug's withdrawal leads to suits against Pfizer
A once-groundbreaking sickle cell disease drug — at the center of a $5.4 billion acquisition two years ago — is the subject ...
Zacks.com on MSN1d
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years?
We recently published a list of the 10 Best Stocks to Buy and Hold For 3 Years. In this article, we are going to take a look ...
bovnews1d
Pfizer Inc (PFE) Stock Trading Recap
On Friday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.36 which represents a slight increase of $0.59 or 2.29% from the prior close of $25.77. The stock opened at $ and touched a ...
bovnews4d
Pfizer Inc (PFE) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Thursday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.77 which represents a decrease of $-0.12 or -0.46% from the prior close of $25.89. The stock opened at $25.7 and touched a low ...
Pfizer: I'm Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call
Pfizer’s financial challenges are offset by growth potential in oncology and strong dividends. Learn why PFE stock is a "Buy" ...
Pfizer’s In-Line Guidance Offers Relief to Weary Investors
Pfizer Inc. forecast 2025 sales and earnings in line with analysts’ projections, a step toward fending off an activist ...
Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis)
Pfizer Inc.'s technical indicators have shifted from bullish to bearish, with the stock now trading below its 30-week EMA and ...
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
Pfizer Inc. (NYSE:PFE) will conduct an investor call on Tuesday to provide full-year 2025 financial guidance. Ahead of the ...
Pfizer (NYSE:PFE) Is Increasing Its Dividend To $0.43
Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...
Pharmabiz1d
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer
Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...